Stay updated on FF-10101-01 Study in Relapsed AML Clinical Trial
Sign up to get notified when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.

Latest updates to the FF-10101-01 Study in Relapsed AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA consolidated Locations section now lists study sites by state (CA, IL, MD, MA, NY, PA) instead of separate state headers, clarifying where the trial is conducted and improving site visibility.SummaryDifference0.7%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedAdded a note that PubMed-listed publications are automatically filled and may not all relate to the study; updated the page revision to v3.3.2.SummaryDifference0.1%

- Check51 days agoChange DetectedRemoved the government funding lapse notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check73 days agoChange DetectedThe page update mainly contains minor wording and formatting changes in sections like the Brief Summary; core study information such as eligibility criteria, primary/secondary outcomes, and enrollment figures remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check94 days agoChange DetectedMajor changes: updated operating status notice and version to v3.2.0; removal of v3.1.0.SummaryDifference3%

- Check101 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0, indicating a new release.SummaryDifference0.1%

Stay in the know with updates to FF-10101-01 Study in Relapsed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.